Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
75 /100
HIGH RISK
Score updated Oct 14, 2026

AIM — AIM ImmunoTech Inc. Dilution Risk Tracker

Track AIM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AIM — Get alerts when the score changes →

As of October 14, 2026, AIM ImmunoTech Inc. (AIM) has a DilutionWatch DilutionScore of 75/100, rated HIGH dilution risk. AIM ImmunoTech Inc. has a market capitalization of $4.93M, 30.44M shares outstanding, 7 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
40
📊 Float Risk
85
⚠️ Warrant Exposure
40
🔄 Convertible Debt
60

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 41%
🔄 Reverse Split model est. 55%
• 50-day avg $0.82 below $1 exchange minimum
🔁 Convertible Conversion model 40%
• Significant convertible debt: 25% potential dilution
• Elevated convertible risk (60/100)
📉 Score Deterioration model 10%
• Score in HIGH risk zone (75/100)
🔔 Track AIM — Get forecast alerts →

Market Data

Market Cap$4.93M
Shares Outstanding30.44M
Float7.99M
Cash$16.41M
Debt$2.30M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore75/100DilutionWatch score record
Shares Outstanding30.44MVerified float table or market cache
Public Float7.99MVerified float table or market cache
Market Cap$4.93MMarket data cache
Cash Runway14.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 8-K 3, EFFECT 2, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

7 institutional holders · 242 shares
#1 Vanguard Group Inc 35 shares
#2 UBS Group AG 1 shares
#3 Geode Capital Management, LLC 34 shares
+ 4 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.41M
Days to Cover1.0
% of Float17.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-07
xbrl XBRL CONVERTIBLE 2022-03-31
8-K 8K EVENT 2026-08-05
8-K 8K EVENT 2026-07-16
EFFECT EFFECT 2026-06-23
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual AIM Dilution Snapshot

AIM ImmunoTech Inc. (AIM) has a DilutionScore of 75/100, rated High dilution risk. Score date: October 14, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

AIM's DilutionScore is currently 75/100 (High risk), with 3 score changes tracked over 45 days. The score deteriorated from 76/100 (Critical risk).

Period Score Risk Level Duration
Oct 14, 202675/100HIGH1 day
Sep 28 – Oct 13, 202676/100CRITICAL16 days
Sep 03 – Sep 27, 202674/100HIGH25 days
Aug 31 – Sep 02, 202656/100HIGH3 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track AIM Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment AIM files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking AIM — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,510+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for AIM
AIM FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.